NCT01692873已完成不适用
Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004
Institut Paoli-Calmettes2 个研究点 分布在 1 个国家目标入组 274 人开始时间: 2012年2月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 274
- 试验地点
- 2
- 主要终点
- Biomarkers
研究概览
简要总结
Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat.
Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month.
The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response.
This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Suspicion of pancreatic adenocarcinoma
- •Patient > 18 years old
- •Social Security affiliation
- •Signed informed consent
排除标准
- •Patient in emergency situation
- •Major person being the object of a legal protective measure or unable to express its consent
研究组 & 干预措施
suspected pancreatic tumor
Experimental
Realization of pancreatic tumor biopsy and blood samples
干预措施: suspected pancreatic tumor (Procedure)
结局指标
主要结局
Biomarkers
时间窗: within twenty four hours
Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers
次要结局
- Histology(within twenty four hours)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive MethodologyPancreatic NeoplasmsNCT04370574University Hospital, Montpellier200
招募中
不适用
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")Pancreatic CancerNCT03311776Inna Chen, MD5,000
Unknown
不适用
Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic CancerPancreatic CancerNCT01127815National Taiwan University Hospital300
进行中（未招募）
不适用
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid BiopsyPancreas AdenocarcinomaNCT04241367National Cancer Center, Korea420
Unknown
不适用
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics TechniquesPatientsNCT05088161The Affiliated Hospital of Qingdao University20